Dr. Eric Yu Mou, MD

Dr. Mou practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Mou's NPI, 1184044398, was assigned on April 27, 2014. Dr. Mou graduated from University of Iowa, RJ & L Carver College of Medicine in 2014. Dr. Mou holds Iowa license MD-47906.

Dr. Mou's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Mou's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Mou is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mou practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mou's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Mou is licensed in Iowa.

CMS data shows 654 Medicare services from Dr. Mou across 9 procedure codes in 2024, for 202 Medicare patients. Medicare paid $48,815 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Dr. Mou in 2024. The largest group is 65 to 74, with 110 patients. 70% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mou's median patient age at 75, with 50% women.

In 2024, Dr. Mou wrote 439 Medicare Part D claims for 70 patients. 77% of them were for generic drugs. CMS names the drug for 330 of them, across 12 drugs with 11 or more claims each, at $940,913 in total drug cost. In 2023, CMS named 304 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Mou for performance year 2024, reported as part of a group. Dr. Mou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mou as offering telehealth.

Dmand AI links 24 papers to Dr. Mou, published from 2017 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Hodgkin Disease, Antineoplastic Combined Chemotherapy Protocols and Biopsy, Large-Core Needle. Dr. Mou has published most often in Blood Adv. Dr. Mou's most frequent co-authors are Lorenzo Falchi, MD, Ronald Balassanian, MD and Caroline Berube, MD.

CMS Open Payments shows 17 general payments to Dr. Mou from 6 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 84% of the total. Acrotech Biopharma LLC paid the most, $3,998. It also lists 2 research payments totaling $995 in 2023.

Dr. Mou graduated from University of Iowa, RJ & L Carver College of Medicine in 2014.